ACC, AHA and HHS Issue Guidelines on Comorbidities in Cardiovascular Disease

Share this content:
ACC, AHA and HHS Issue Guidelines on Comorbidities in Cardiovascular Disease
ACC, AHA and HHS Issue Guidelines on Comorbidities in Cardiovascular Disease

(HealthDay News) — Comorbid conditions must be considered when applying clinical practice guidelines to the treatment of cardiovascular disease, according to an article published in the Journal of the American College of Cardiology.

Donna K. Arnett, MSPH, PhD, of the University of Alabama in Birmingham, and colleagues from the American Heart Association, the American College of Cardiology and the U.S. Department of Health and Human Services, reviewed Medicare claims for 2012 and jointly issued a clinical practice guideline addressing common comorbidities in patients with selected cardiovascular (CV) conditions. 

The four cardiovascular conditions selected for analysis were ischemic heart disease, heart failure, atrial fibrillation and stroke.

For patients with ischemic heart disease, the prevalent comorbidities were hypertension, hyperlipidemia and diabetes. For patients with heart failure, atrial fibrillation or stroke, the most prevalent comorbidities were hypertension, hyperlipidemia and ischemic heart disease. 

For patients with dyads or triads of chronic conditions, combinations of high cholesterol, high blood pressure and ischemic heart disease were common.

"Incorporating major comorbidities into future clinical practice guidelines will be challenging; however, this large analysis helps by identifying those comorbidities which are most prevalent," Arnett said in a statement.

Reference

  1. Arnett DK et al. J Am Coll Cardiol. 2014;doi:10.1016/j.jacc.2014.07.012.
You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus